HUMAN CYTOKINE LINCOplex KIT
By purchasing this product, which contains fluorescently labeled microsphere beads authorized by Luminex Corporation ("Luminex"), you, the customer, acquire the right under Luminex's patent rights, if any, to use this product or any portion of this product, including without limitation the microsphere beads contained herein, only with Luminex's laser based fluorescent analytical test instrumentation marketed under the name of Luminex100.
This is a multiplex assay kit manufactured by Linco Research to be used for the simultaneous quantitative determination of the following human cytokines and chemokines: IL-1α, IL-1b , IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, Eotaxin, IFNg, G-CSF, GM-CSF, IP-10, MCP-1, MIP-1α, RANTES and TNFa premixed as a 13, 21, or 22 plex. This kit may be used for the analysis of all of the above cytokines and chemokines in tissue/cell lysate and culture supernatant samples. This kit may also be used in undiluted serum, plasma, other body fluids, and tissue extract samples for the analysis of all of the above cytokines and chemokines except RANTES because of high concentrations of RANTES in the blood. Serum or plasma samples should be diluted 1:50 when the kit is used for analyzing RANTES. Single-plex RANTES, IL-10, and TNFα kits are also available from Linco Research
This kit is for research purposes only.
A. Antibody-Immobilized Premixed Beads
Quantity: 3.5ml/bottle
The following bead sets are premixed in the Bead Bottle:
|
13 Plex Premix Beads |
21 Plex Premix Beads |
22 Plex Premix Beads |
|
#01-Human IL-1β #03-Human IL-2 #09-Human IL-4 #10-Human IL-5 #12-Human IL-6 #13-Human IL-7 #20-Human IL-8 #23-Human IL-10 #25-Human IL-12p70 #26-Human IL-13 #35-Human IFNg #39-Human GM-CSF #40-Human TNFα
|
#32-Human IL-1α #01-Human IL-1β #03-Human IL-2 #09-Human IL-4 #10-Human IL-5 #12-Human IL-6 #13-Human IL-7 #20-Human IL-8 #23-Human IL-10 #25-Human IL12p70 #26-Human IL-13 #28-Human IL-15 #30-Human IL-17 #35-Human IFNg #37-Human G-CSF #39-Human GM-CSF #40-Human TNF #46-Human MCP-1 #57-Human MIP-1α #65-Human IP-10
|
#32-Human IL-1α
#01-Human IL-1β #03-Human IL-2 #09-Human IL-4 #10-Human IL-5 #12-Human IL-6 #13-Human IL-7 #20-Human IL-8 #23-Human IL-10 #25-Human IL-12p70 #26-Human IL-13 #28-Human IL-15 #30-Human IL-17 #35-Human IFNg #37-Human G-CSF #39-Human GM-CSF #40-Human TNFα #44-Human Eotaxin #46-Human MCP-1 #57-Human MIP-1α #65-Human IP-10
|
B. Human Cytokine/Chemokine Standard Cocktail
1 vial containing human cytokine standard cocktail, lyophilized
Quantity: 1 vial
C. Human Cytokine/Chemokine Quality Controls
Control I – 1 vial containing mixed cytokine cocktail, lyophilized
Control II – 1 vial containing mixed cytokine cocktail, lyophilized
Quantity: 1 vial/Control
D. Serum Matrix, lyophilized (optional – for serum/plasma samples)
Serum containing 0.08% Sodium Azide
Quantity: 1 ml/vial
E. Human Cytokine/Chemokine Detection Antibodies
1 bottle containing a cocktail of biotinylated detection antibodies in Assay Buffer
Quantity: 3.2 ml/bottle
F. Streptavidin-Phycoerythrin
1 bottle containing Streptavidin-Phycoerythrin prepared in Assay Buffer
Quantity: 3.2 ml/bottle
G. Assay Buffer
50 mM PBS with 25 mM EDTA, 0.08% Sodium Azide, 0.05% Tween 20, and 1% BSA, pH 7.4.
Quantity: 30 ml/bottle
H. 10X Wash Buffer
1:10 dilution required with deionized water to give 10 mM PBS with 0.05% Proclin, and 0.05% Tween 20, pH 7.4.
Quantity: 30 ml/bottle
I. Microtiter Filter Plate
Quantity: 1- 96 Well Filtration Plate
J. Plate Sealers
Quantity: 2 Plate Sealers
III. STORAGE CONDITIONS UPON RECEIPT
Recommended storage for kit components is 2 - 8°C. See individual vials for long-term storage recommendations.
Once the standards and controls have been reconstituted, immediately transfer contents into polypropylene vials. DO NOT STORE RECONSTITUTED STANDARDS OR CONTROLS IN GLASS VIALS. For long-term storage, freeze reconstituted standards and controls at £ -20°C. Avoid multiple (>2) freeze/thaw cycles.
DO NOT FREEZE Antibody-Immobilized Beads, Detection Antibody, and Streptavidin-Phycoerythrin.
Sodium Azide has been added to some reagents as a preservative. Although the concentrations are low, sodium azide may react with lead and copper plumbing to form highly explosive metal azides. On disposal, flush with a large volume of water to prevent azide build up.
V. MATERIALS REQUIRED BUT NOT PROVIDED
A. Reagents
Luminex Sheath Fluid (Luminex Catalogue #40-50000)
B. Instrumentation/Materials
1. Adjustable Pipettes with Tips capable of delivering 25 m l to 1000 m l
2. Multichannel Pipettes capable of delivering 5 m l to 50 m l or 25 m l to 200 m l
3. Reagent Reservoirs
4. Polypropylene Microfuge Tubes
5. Aluminum Foil
6. Absorbent Pads
7. Laboratory Vortex
8. Sonicator (Branson Ultrasonic Cleaner, Model # B200 or equivalent)
9. Titer Plate Shaker (Lab-Line Instruments, Model #4625, or equivalent)
10. Vacuum Filtration Unit (Millipore Vacuum Manifold Catalogue #MAVM0960R, or equivalent)
11. Luminex100 by Luminex Corporation
VI. SPECIMEN COLLECTION AND STORAGE
A. A maximum of 25 m l per well of serum or plasma can be used. Tissue culture or other media may also be used.
B. Preparation of Tissue Culture Supernatant:
Centrifuge the sample to remove debris and assay immediately or aliquot and store samples at £ -20ºC. Avoid multiple (>2) freeze/thaw cycles. Tissue Culture Supernatant may require a dilution with the appropriate medium prior to assay.
C. Preparation of Serum Samples:
Allow the blood to clot for at least 30 minutes before centrifugation for 10 minutes at 1000 Xg. Remove serum and assay immediately or aliquot and store samples at £ -20ºC. Avoid multiple (>2) freeze/thaw cycles. It is recommended to centrifuge samples again prior to assay setup. Except for RANTES, use Serum Matrix as the diluent for quantifying cytokines/chemokines in serum or plasma samples. When RANTES is quantified, Assay Buffer should be used as diluent for blood samples. When RANTES is measured, samples should be diluted 1:50 in the assay buffer and a standard curve with assay buffer matrix should be used accordingly.
D. Preparation of Plasma Samples:
Plasma collection using EDTA as an anti-coagulant is recommended. Centrifuge for 10 minutes at 1000 Xg within 30 minutes of blood collection. Remove plasma and assay immediately or aliquot and store samples at £ -20ºC. Avoid multiple (>2) freeze/thaw cycles. Except for RANTES, use Serum Matrix as the diluent for quantifying cytokines/chemokines in serum or plasma samples. When RANTES is quantified, Assay Buffer should be used as diluent for blood samples. When RANTES is measured, samples should be diluted 1:50 in the assay buffer and a standard curve with assay buffer matrix should be used accordingly.
E. All samples must be stored in polypropylene tubes. DO NOT STORE SAMPLES IN GLASS.
F. Avoid using samples with gross hemolysis or lipemia.
G. Care must be taken when using heparin as an anticoagulant, since an excess of heparin will provide falsely high values. Use no more than 10 IU heparin per ml of blood collected.
To obtain reliable and reproducible results, the operator should carefully read this entire manual and fully understand all aspects of each assay step before running the assay. The following notes should be reviewed and understood before the assay is set-up.
A. The Antibody-Immobilized Beads are light sensitive and must be covered with aluminum foil at all times. Cover the assay plate containing beads with aluminum foil during all incubation steps.
B. It is critical to allow all reagents to warm to room temperature (20-25° C) before use in the assay.
C. The bottom of the Microtiter Filter Plate should not be in direct contact with any absorbent material during assay set-up or incubation times. The plate can be set on the non-flat side of the plate cover or any other plate holder to raise the plate from the surface.
D. After the wash steps, keep the bottom of the Microtiter Filter Plate clean by blotting on paper towels or absorbent pads to prevent any leakage due to capillary action.
E. Keep the vacuum suction on the plate as low as possible. It is recommended to have a vacuum setting that will remove 200 ml of buffer in > 5 seconds (equivalent to < 100 mmHg).
F. After hydration, all standards and controls must be transferred to polypropylene tubes.
G. The standards prepared by serial dilution must be used within 1 hour of preparation. Discard any unused standards except the 10 ng/ml stock standard which may be stored at £ -20° C for 1 month and at £ -80° C for greater than one month.
H. Any unused mixed Antibody-Immobilized Beads may be stored in the bead mix bottle at 2-8° C for up to one month.
I. During the preparation of the standard curve, make certain to vortex the higher concentration well before making the next dilution. Use a fresh tip with each dilution.
J. The plate should be read immediately after the assay is finished. If, however, the plate cannot be read immediately, seal the plate, cover with aluminum foil, and store at 2-8° C for up to 24 hours. Prior to reading, agitate the plate on the plate shaker at room temperature for 10 minutes. Delay in reading a plate may result in decreased sensitivity for some cytokines and chemokines.
K. The titer plate shaker should be set at a speed to provide maximum agitation without splashing of liquid outside the wells. For the recommended plate shaker, this would be a setting of 5-7, which is approximately 500-800 rpm.
L. Ensure the needle probe is clean. This may be achieved by sonication and/or Alcohol Flushes. Adjust probe height to the Lincoplex filter plate prior to reading an assay.
M. For cell culture supernatants or tissue extraction, use the culture or extraction medium as matrix in blank, standard curve and controls. If samples are diluted in Assay Buffer, use the Assay Buffer as matrix.
VIII. PREPARATION OF REAGENTS FOR IMMUNOASSAY
A. Preparation of Antibody-Immobilized Beads
Antibody-Immobilized Beads are premixed. Sonicate and/or vortex before use.
B. Preparation of Human Cytokine Standard Cocktail
1.) Prior to use, reconstitute the Human Cytokine Standard Cocktail with 250 ml Deionized Water to give a 10,000 pg/ml concentration of standard. Invert the vial several times to mix. Vortex the vial for 10 seconds. Allow the vial to set for 5-10 minutes and then transfer the standard to appropriately labeled polypropylene microfuge tube. This will be used as the 10,000 pg/ml standard; the unused portions may be stored at £ -20° for up to one month.
2). Preparation of Working Standards
Label five polypropylene microfuge tubes 2000, 400, 80, 16, and 3.2 pg/ml. Add 200 ml of Assay Buffer to each of the five tubes. Prepare serial dilutions by adding 50 ml of the 10,000 pg/ml reconstituted standard to the 2000 pg/ml tube, mix well and transfer 50 ml of the 2000 standard to the 400 pg/ml tube, mix well and transfer 50 ml of the 400 standard to the 80 pg/ml tube, mix well and transfer 50 ml of the 80 standard to 16 pg/ml tube, mix well and transfer 50 ml of the 16 pg/ml standard to the 3.2 pg/ml tube and mix well. The 0 pg/ml standard (Background) will be Assay Buffer.
|
Standard Concentration |
Volume of Deionized Water to Add |
Volume of Standard |
|
10,000 |
250 ml |
0 |
|
Standard Concentration |
Volume of Assay Buffer to Add |
Volume of Standard |
|
2000 |
200 ml |
50 ml of 10,000 pg/ml |
|
400 |
200 ml |
50 ml of 2000 pg/ml |
|
80 |
200 ml |
50 ml of 400 pg/ml |
|
16 |
200 ml |
50 ml of 80 pg/ml |
|
3.2 |
200 ml |
50 ml of 16 pg/ml |
C. Preparation of Controls
Before use, reconstitute Human Cytokine Control I and Human Cytokine Control II with 250 ml Deionized Water. Invert the vial several times to mix and vortex. Allow the vial to set for 5-10 minutes and then transfer the controls to an appropriately labeled polypropylene microfuge tube. Unused portions may be stored at £ -20° for up to one month.
D. Preparation of Wash Buffer
Bring the 10X Wash Buffer to room temperature and mix to bring all salts into solution. Dilute 30 ml of 10X Wash Buffer with 270 ml deionized water. Store unused portions at 2-8° C for up to one month.
E. Preparation of Serum Matrix
This step is required for serum or plasma samples only.
Add 1.0 mL deionized water to the bottle containing lyophilized Serum Matrix. Mix well. Allow at least 10 minutes for complete reconstitution. Left-over reconstituted Serum Matrix should be stored at £ -20° for up to one month.
Prior to beginning this assay, it is imperative to read this protocol completely and to thoroughly understand the Technical Guidelines outlined in Section VII.
Allow all reagents to warm to room temperature (20-25° C) before use in the assay.
1. Diagram placement of Standards, 0 (Background) 3.2, 16, 80, 400, 2000, and 10,000 pg/ml, Controls I and II, and samples on Well Map Worksheet in a vertical configuration. (Note: the instrument will only read the 96-well plate vertically). It is recommended to run the assay in duplicate.
2. Block the filter plate by pipetting 200 µL of Assay Buffer into each well of the microtiter plate. Seal and mix on a plate shaker for 10 minutes at room temperature (20-25° C).
3. Remove Assay Buffer by vacuum. (NOTE: DO NOT INVERT PLATE). Remove any excess Assay Buffer from the bottom of the plate by blotting on an absorbent pad or paper towels.
4. Add 25 µL of Assay Buffer to the 0 Standard (Background).
5. Add 25 µL of Assay Buffer to the Sample wells.
6. Add 25 µL of each Standard or Control into the appropriate wells.
7. Add 25 µL of appropriate matrix diluent to the Background, Standards, and Control wells. When assaying serum or plasma, use Serum Matrix provided in the kit. When assaying Tissue Culture or other supernatant, use proper control medium as the diluent.
8. Add 25 µL of Sample into the appropriate wells.
9. Vortex Bead Bottle and add 25 μL of the Mixed Beads to each well. (Note: during addition of Mixed Beads, shake bead mix intermittently to avoid settling)
10. Seal, cover with aluminum foil, and incubate with agitation on a plate shaker for 1 hour at room temperature (20-25° C).
11. Gently remove fluid by vacuum. (NOTE: DO NOT INVERT PLATE).
12. Wash plate 2 times with 200 µL/well of Wash Buffer, removing Wash Buffer by vacuum filtration between each wash. Remove any excess Wash Buffer from the bottom the plate by blotting on an absorbent pad or paper towels.
13. Add 25 µL of Detection Antibody Cocktail into each well. (Note: allow the Detection Antibody to warm to room temperature prior to addition.)
14. Seal, cover with aluminum foil, and incubate with agitation on a plate shaker for 30 minutes at room temperature (20-25° C). DO NOT VACUUM AFTER INCUBATION.
15. Add 25 m L Streptavidin-Phycoerythrin to each well containing the 25 m L of Detection Antibody Cocktail.
16. Seal, cover with aluminum foil, and incubate with agitation on a plate shaker for 30 minutes at room temperature (20-25° C).
17. Gently remove all contents by vacuum. (NOTE: DO NOT INVERT PLATE).
18. Wash plate 2 times with 200 µL/well Wash Buffer, removing Wash Buffer by vacuum filtration between each wash. Wipe any excess buffer on the bottom of the plate with a tissue.
19. Add 100 µL of Sheath Fluid to all wells. Cover with aluminum foil and resuspend the beads on a plate shaker for 5 minutes.
20. Run plate on Luminex100.
21. Save and evaluate the median data using a 5-parameter logistic or spline curve-fitting method for calculating cytokine/chemokines concentrations in samples.
Select the following equipment settings:
| Events: | 50, per bead | ||
| Sample Size: | 50 ml | ||
| Bead Set: | 13 Plex Premix Beads | 21 Plex Premix Beads | 22 Plex Premix Beads |
| 01 for IL-1b | 01 for IL-1b | 01 for IL-1b | |
| 03 for IL-2 | 03 for IL-2 | 03 for IL-2 | |
| 09 for IL-4 | 09 for IL-4 | 09 for IL-4 | |
| 10 for IL-5 | 10 for IL-5 | 10 for IL-5 | |
| 12 for IL-6 | 12 for IL-6 | 12 for IL-6 | |
| 13 for IL-7 | 13 for IL-7 | 13 for IL-7 | |
| 20 for IL-8 | 20 for IL-8 | 20 for IL-8 | |
| 23 for IL-10 | 23 for IL-10 | 23 for IL-10 | |
| 25 for IL-12(p70) | 25 for IL-12(p70) | 25 for IL-12(p70) | |
| 26 for IL-13 | 26 for IL-13 | 26 for IL-13 | |
| 35 for IFNg | 28 for IL-15 | 28 for IL-15 | |
| 39 for GM-CSF | 30 for IL-17 | 30 for IL-17 | |
| 40 for TNFa | 32 for IL-1α | 32 for IL-1α | |
| 35 for IFNg | 35 for IFNg | ||
| 37 for G-CSF | 37 for G-CSF | ||
| 39 for GM-CSF | 39 for GM-CSF | ||
| 40 for TNFa | 40 for TNFa | ||
| 44 for Eotaxin | 44 for Eotaxin | ||
| 46 for MCP-1 | 46 for MCP-1 | ||
| 57 for MIP-1α | 57 for MIP-1α | ||
| 65 for IP-10 | 65 for IP-10 | ||
| 69 for RANTES | |||
| *Gate (for IS System): | 8,000 to 15,000 |
| *Gate (for 1.7 System): | 8,060 to 13,000 |
*These specifications are for the Luminex100v.1.7 or Luminex100IS v2.1/2.2. Luminex instruments with other software (e.g. Masterplex, Starstation, LiquiChip, Bioplex, LABScan100) would need to follow instrument instructions for gate settings and additional specifications.
The ranges for each analyte in Quality Control I and II are provided on the card insert or can be located at the Linco Research website www.lincoresearch.com.
A. Standard Comparison
The following LINCOplex standards with known values of mass and standards received from the National Institute of Biological Standards and Controls with assigned Bioassay units and approximate mass determinations were assayed together to provide the following conversion factor:
|
Cytokine |
NCI Lot # |
1 Lincoplex pg/ml = |
|
IL-1b |
86/680 |
303 mIU/ml |
|
IL-2 |
86/504 |
13 mIU/ml |
|
IL-4 |
88/656 |
3.6 mIU/ml |
|
IL-5 |
90/586 |
70 mIU/ml |
|
IL-6 |
88/514 |
3.9 mIU/ml |
|
IL-7 |
To be determined |
To be determined |
|
IL-8 |
89/520 |
10.4 mIU/ml |
|
IL-10 |
92/516 |
3.8 mIU/ml |
|
IL-12(p70) |
Not Available |
- |
|
IL-13 |
To be determined |
To be determined |
|
GM-CSF |
88/646 |
30 mIU/ml |
|
TNFa |
87/650 |
154 mIU/ml |
The following LINCOplex standard with known values of mass and standards received from the NIAID Reference Reagent Repository with assigned Bioassay units and approximate mass determinations were assayed together to provide the following conversion factor:
|
Cytokine |
NCI Lot # |
1 Lincoplex pg/ml = |
|
IFNg |
Gxg01-902-535 |
12.8 mIU/ml |
B. Precision
|
Cytokine |
Intra-assay Precision (%CV) |
Interassay |
|
IL-1b |
7.8 |
8.7 |
|
IL-2 |
7.5 |
8.0 |
|
IL-4 |
6.2 |
14.1 |
|
IL-5 |
6.3 |
14.5 |
|
IL-6 |
6.3 |
10.4 |
|
IL-7 |
4.6 |
3.1 |
|
IL-8 |
6.0 |
9.0 |
|
IL-10 |
5.4 |
11.2 |
|
IL-12(p70) |
7.6 |
18.4 |
|
IL-13 |
6.0 |
4.9 |
|
IL-15 |
6.9 |
9.6 |
|
IL-17 |
6.0 |
9.2 |
|
IL-1α |
9.0 |
12.0 |
|
IFNg |
5.3 |
10.3 |
|
G-CSF |
7.0 |
18.7 |
|
GM-CSF |
7.3 |
15.7 |
|
TNFa |
5.8 |
9.4 |
|
Eotaxin |
3.8 |
9.7 |
|
MCP-1 |
11.1 |
13.7 |
|
MIP-1α |
4.4 |
24.6 |
|
IP-10 |
4.3 |
14.0 |
|
RANTES |
1.6 |
13.3 |
Intra-assay precision is generated from the mean of the %CV’s from 8 reportable results across two different concentration of cytokines in a single assay. Interassay precision is generated from the mean of the %CV’s from 5 reportable results across three different concentrations of cytokine across six different assays.
C. Accuracy
|
Cytokine |
%Recovery |
|
IL-1b |
108 |
|
IL-2 |
89 |
|
IL-4 |
87 |
|
IL-5 |
93 |
|
IL-6 |
98 |
|
IL-7 |
107 |
|
IL-8 |
95 |
|
IL-10 |
113 |
|
IL-12(p70) |
94 |
|
IL-13 |
83 |
|
IL-15 |
115 |
|
IL-17 |
98 |
|
IL-1α |
79 |
|
IFNg |
85 |
|
G-CSF |
104 |
|
GM-CSF |
116 |
|
TNFa |
98 |
|
Eotaxin |
85 |
|
MCP-1 |
91 |
|
MIP-1α |
83 |
|
IP-10 |
101 |
|
RANTES |
108 |
Accuracy, defined as Percent Recovery, is generated from calculating the %Recovery of three different levels of cytokine spiked into 6 different human serum samples with known low or no measurable cytokine levels.
D. Linearity of Dilution (% Neat Serum Sample Concentrations)
|
Cytokine |
1:2 Dilution |
1:4 Dilution |
1:8 Dilution |
|
IL-1b |
106 |
108 |
108 |
|
IL-2 |
115 |
119 |
119 |
|
IL-4 |
102 |
102 |
92 |
|
IL-5 |
92 |
91 |
92 |
|
IL-6 |
110 |
109 |
106 |
|
IL-7 |
108 |
113 |
113 |
|
IL-8 |
104 |
105 |
102 |
|
IL-10 |
103 |
105 |
104 |
|
IL-12(p70) |
105 |
109 |
108 |
|
IL-13 |
99 |
92 |
85 |
|
IL-15 |
113 |
124 |
138 |
|
IL-17 |
111 |
115 |
119 |
|
IL-1α |
100 |
124 |
130 |
|
IFNg |
101 |
105 |
109 |
|
G-CSF |
130 |
118 |
119 |
|
GM-CSF |
112 |
110 |
108 |
|
TNFa |
100 |
132 |
126 |
|
Eotaxin |
112 |
118 |
114 |
|
MCP-1 |
100 |
142 |
125 |
|
MIP-1α |
102 |
107 |
100 |
|
IP-10 |
96 |
98 |
95 |
|
RANTES |
100* |
101* |
102* |
*RANTES samples were diluted 1:100, 1:200, 1:400.
E. Cross-Reactivity
There was no significant cross-reactivity between the antibodies and any of the other analytes in this panel.
| REAGENTS | Cat # |
| Set of two 96-Well Filter Plates with sealers | L-PLATE |
| Assay Buffer | L-AB |
| 10X Wash Buffer | L-WB |
| Human Cytokine/Chemokine Standard Cocktail | L-8060 |
| Human Cytokine/Chemokine Quality Controls | L-6060 |
| Serum Matrix | LHC-SD22 (optional) |
| Human Cytokine/Chemokine Detection Antibodies
(Use with Cat.# HCB-PMX13) (Use with Cat.# HCB-PMX21) (Use with Cat.# HCB-PMX22) |
L-1060-1
L-1060-2 L-1060-2 |
| Streptavidin-Phycoerythrin
(Use with Cat.# L-1060-1) (Use with Cat.# L-1060-2) |
L-SAPE3
L-SAPE4 |
| 13 Plex Premixed Beads:
(hIL-1β, hIL-2, hIL-4, hIL-5, hIL-6, hIL-7, hIL-8, hIL-10, hIL-12p70, hIL-13,hGM-CSF, hIFNγ, hTNFα) |
HCB-PMX13 |
| 21 Plex Premixed Beads:
(hIL-1α, hIL-1β, hIL-2, hIL-4, hIL-5, hIL-6, hIL-7, hIL-8, hIL-10, hIL-12p70, hIL-13, hIL-15, hIL-17, hEotaxin, hG-CSF, hGM-CSF, hIFNγ, hIP-10, hMCP-1, hMIP-1α, hTNFα) |
HCB-PMX21 |
| 22 Plex Premixed Beads:
(hIL-1α, hIL-1β, hIL-2, hIL-4, hIL-5, hIL-6, hIL-7, hIL-8, hIL-10, hIL-12p70, hIL-13, hIL-15, hIL-17, hEotaxin, hG-CSF, hGM-CSF, hIFNγ, hIP-10, hMCP-1, hMIP-1α, hTNFα and RANTES) |